Nivolumab-induced cold agglutinin syndrome successfully treated with rituximab

•Cold agglutinin syndrome is one of the rare immune-related adverse events of nivolumab.•Rituximab should be considered for treatment of nivolumab-induced cold agglutinin syndrome.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood advances 2018-08, Vol.2 (15), p.1865-1868
Hauptverfasser:	Hasanov, Merve, Konoplev, Sergej N., Hernandez, Cristhiam M. Rojas
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged, 80 and over Anemia, Hemolytic, Autoimmune - chemically induced Anemia, Hemolytic, Autoimmune - drug therapy Anemia, Hemolytic, Autoimmune - pathology Breast Neoplasms - drug therapy Breast Neoplasms - pathology Carboplatin - administration & dosage Carboplatin - adverse effects Deoxycytidine - administration & dosage Deoxycytidine - adverse effects Deoxycytidine - analogs & derivatives Exceptional Case Report Female Humans Lymphoma, B-Cell, Marginal Zone - drug therapy Lymphoma, B-Cell, Marginal Zone - pathology Neoplasms, Second Primary - chemically induced Neoplasms, Second Primary - drug therapy Neoplasms, Second Primary - pathology Nivolumab - administration & dosage Nivolumab - adverse effects Rituximab - administration & dosage Syndrome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	•Cold agglutinin syndrome is one of the rare immune-related adverse events of nivolumab.•Rituximab should be considered for treatment of nivolumab-induced cold agglutinin syndrome.
ISSN:	2473-9529 2473-9537
DOI:	10.1182/bloodadvances.2018019000